ACE2 and infection: While SARS-CoV and SARS-CoV-2 use ACE2, we consider that this is not an essential condition of viral spillover as other human CoVs do not use ACE2 (16, 17), and any vaccine designed for maximal coverage of betaCoVs should prevent infection irrespective of receptor usage.